Oracle Corporation
At today's price, Oracle Corporation (ORCL) is priced for +14.1% growth. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high. Built from SEC EDGAR filings.
- At $183.89 (as of June 27, 2026) the price pays roughly 29x company-wide operating income, a level that needs operating profit to compound about 24.8% a year for five years. Oracle has not grown that fast over a full cycle, so the price is a forward bet, not a description of the trailing record. - The X-ray splits cleanly by family. Growth-DCF and peer-multiple methods land near the price (DCF Perpetual $195, Relative Valuation $187, EV/EBITDA Relative $186), while every asset and earnings-pow
Is ORCL overvalued? See what's priced in →
3,391 institutional managers reported holding ORCL in 13F filings for the quarter ended 2026-03-31. Together they hold about 40% of the company; the top 10 hold 20%. 140 opened new positions that quarter. Held by Vanguard Group, BlackRock, State Street, among others. On the short side, 37.7M shares were sold short as of the 2026-06-15 count, about 1% of shares outstanding (1.2 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
ORCL's share count grew 3.8% over the past five years even with $19.45B spent on repurchases. It pays a dividend, and has paid one every year in our records (17 and counting), raised 16 years straight; the current rate is $2.00 a share annually. Cash returned over the past three years: $14.92B in dividends and $1.90B in repurchases.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
Open-market insider buys at ORCL over the trailing three years: 2025: 2 buys totaling $1.06M. 21 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
ORCL's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-06-21 | +6.2% | -3.5% |
| 2023-09-13 | -13.2% | +2.0% |
| 2023-12-13 | -11.3% | +10.9% |
| 2024-03-13 | +13.4% | -3.1% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
ORCL's latest 8-K filings: 2026-06-10 (items 2.02, 8.01, 9.01); 2026-05-12 (items 5.02, 7.01, 9.01); 2026-04-06 (items 5.02, 7.01, 9.01); 2026-03-10 (items 2.02, 8.01, 9.01); 2026-02-05 (items 1.01, 3.03, 5.03, 9.01).
Item codes are the SEC's own classification of what each report discloses. Nothing here is investment advice.
Last analyzed: July 3, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.